Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04248569
Brief Title: DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolamellar Hepatocellular Carcinoma

First Submitted : January 28, 2020
First Submitted that Met QC Criteria : January 28, 2020
First Posted : January 30, 2020

Last Update Submitted that Met QC Criteria : August 5, 2021
Last Update Posted : August 12, 2021